Literature DB >> 27641077

Interspecies comparison of the functional characteristics of plasma membrane monoamine transporter (PMAT) between human, rat and mouse.

Yoshiyuki Shirasaka1, Nora Lee2, Haichuan Duan2, Horace Ho2, Joanna Pak2, Joanne Wang3.   

Abstract

Plasma membrane monoamine transporter (PMAT) is a newly discovered monoamine transporter belonging to the equilibrative nucleoside transporter family. Highly expressed in the brain, PMAT represents a major uptake2 transporter that may play a role in monoamine clearance. Although human PMAT has been functionally characterized at the molecular level, rodent models are often used to evaluate PMAT function in ex vivo and in vivo studies. The aim of this study was to examine if there is potential species difference in the functional characteristics of PMAT between human, rat and mouse. A set of transfected cells stably expressing human PMAT (MDCK/hPMAT), rat Pmat (MDCK/rPmat) and mouse Pmat (Flp293/mPmat) were constructed. In MDCK/hPMAT, MDCK/rPmat and Flp293/mPmat cells, cellular localization analyses revealed that hPMAT, rPmat and mPmat are expressed and mainly localized to the plasma membranes of cells. The uptake of MPP+, serotonin and dopamine by MDCK/hPMAT, MDCK/rPmat and Flp293/mPmat cells was significantly increased compared with those by the mock transfection control. In contrast, two nucleosides, uridine and adenosine, minimally interacted with PMAT/Pmat in all species. The hPMAT-, rPmat- and mPmat-mediated uptakes of MPP+, serotonin and dopamine were saturable, with Km values of 33.7μM, 70.2μM and 49.5μM (MPP+), 116μM, 82.9μM and 231μM (serotonin), and 201μM, 271μM and 466μM (dopamine), respectively, suggesting similar substrate affinities between human and rodent PMAT/Pmat. The prototypical inhibitors, decynium 22 and GBR12935, also showed similar inhibition potencies between species. In conclusion, the present study demonstrated interspecies similarities in the functional characteristics of human and rodent PMAT/Pmat, which indicate a practical utility of rat and mouse animal models for further investigating and extrapolating the in vivo function of PMAT in humans.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Human; Monoamine; Mouse; PMAT; Rat; Species difference

Mesh:

Substances:

Year:  2016        PMID: 27641077      PMCID: PMC5352556          DOI: 10.1016/j.jchemneu.2016.09.006

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  21 in total

Review 1.  Molecular and cellular physiology of renal organic cation and anion transport.

Authors:  Stephen H Wright; William H Dantzler
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

Review 2.  Management of diabetes from preconception to the postnatal period: summary of NICE guidance.

Authors: 
Journal:  BMJ       Date:  2008-03-29

3.  Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations.

Authors:  Mingyan Zhou; Haichuan Duan; Karen Engel; Li Xia; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2010-06-30       Impact factor: 3.922

4.  Expression and immunolocalization of the plasma membrane monoamine transporter in the brain.

Authors:  A Dahlin; L Xia; W Kong; R Hevner; J Wang
Journal:  Neuroscience       Date:  2007-04-03       Impact factor: 3.590

5.  Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers.

Authors:  Takashi Okura; Sayaka Kato; Yusuke Takano; Takenori Sato; Atsushi Yamashita; Riyo Morimoto; Sumio Ohtsuki; Tetsuya Terasaki; Yoshiharu Deguchi
Journal:  J Pharm Sci       Date:  2011-05-02       Impact factor: 3.534

6.  Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.

Authors:  Haichuan Duan; Joanne Wang
Journal:  J Pharmacol Exp Ther       Date:  2010-09-21       Impact factor: 4.030

7.  rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger.

Authors:  D H Sweet; J B Pritchard
Journal:  Am J Physiol       Date:  1999-12

8.  Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family.

Authors:  Mingyan Zhou; Li Xia; Karen Engel; Joanne Wang
Journal:  J Biol Chem       Date:  2006-11-22       Impact factor: 5.157

9.  Involvement of carnitine/organic cation transporter OCTN1/SLC22A4 in gastrointestinal absorption of metformin.

Authors:  Noritaka Nakamichi; Hiroyo Shima; Satoshi Asano; Takahiro Ishimoto; Tomoko Sugiura; Kazuki Matsubara; Hiroyuki Kusuhara; Yuichi Sugiyama; Yoshimichi Sai; Ken-Ichi Miyamoto; Akira Tsuji; Yukio Kato
Journal:  J Pharm Sci       Date:  2013-05-10       Impact factor: 3.534

Review 10.  Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.

Authors:  Hermann Koepsell; Katrin Lips; Christopher Volk
Journal:  Pharm Res       Date:  2007-05-01       Impact factor: 4.580

View more
  5 in total

1.  Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours.

Authors:  T Lee Gilman; Christina M George; Melissa Vitela; Myrna Herrera-Rosales; Mohamed S Basiouny; Wouter Koek; Lynette C Daws
Journal:  Eur J Neurosci       Date:  2018-05-24       Impact factor: 3.386

Review 2.  The Interaction of Organic Cation Transporters 1-3 and PMAT with Psychoactive Substances.

Authors:  Julian Maier; Marco Niello; Deborah Rudin; Lynette C Daws; Harald H Sitte
Journal:  Handb Exp Pharmacol       Date:  2021

3.  Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter.

Authors:  Rheaclare Fraser-Spears; Anwen M Krause-Heuer; Mohamed Basiouny; Felix P Mayer; Retrouvailles Manishimwe; Naomi A Wyatt; Jeremy C Dobrowolski; Maxine P Roberts; Ivan Greguric; Naresh Kumar; Wouter Koek; Harald H Sitte; Paul D Callaghan; Benjamin H Fraser; Lynette C Daws
Journal:  Eur J Pharmacol       Date:  2018-10-25       Impact factor: 5.195

4.  Uncovering Functional Contributions of PMAT (Slc29a4) to Monoamine Clearance Using Pharmacobehavioral Tools.

Authors:  Jasmin N Beaver; Brady L Weber; Matthew T Ford; Anna E Anello; Sarah K Kassis; T Lee Gilman
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

5.  Deletion of murine slc29a4 modifies vascular responses to adenosine and 5-hydroxytryptamine in a sexually dimorphic manner.

Authors:  Ran Wei; Stephen L Gust; David Tandio; Alexia Maheux; Khanh H Nguyen; Joanne Wang; Stephane Bourque; Frances Plane; James R Hammond
Journal:  Physiol Rep       Date:  2020-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.